Efficiency of Pulmonary Administration of Tobramycin Solution for Inhalation in Cystic Fibrosis Using an Improved Drug Delivery System
- 1 January 2003
- Vol. 123 (1) , 28-36
- https://doi.org/10.1378/chest.123.1.28
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The diagnosis of cystic fibrosis: A consensus statementThe Journal of Pediatrics, 1998
- Aerosolized Antibiotics for Bacterial Lower Airway InfectionsClinical Pulmonary Medicine, 1997
- Drug Uptake in the TracheaJournal of Aerosol Medicine, 1996
- TOBRAMYCIN SERUM CONCENTRATIONS AFTER AEROSOL AND ORAL ADMINISTRATION IN CYSTIC FIBROSISClinical Journal of Sport Medicine, 1995
- Nebulizer delivery of tobramycin to the lower respiratory tractPediatric Pulmonology, 1994
- Efficacy of Aerosolized Tobramycin in Patients with Cystic FibrosisNew England Journal of Medicine, 1993
- Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosisPediatric Pulmonology, 1989
- Bioactivity of Gentamicin in Purulent Sputum from Patients with Cystic Fibrosis or Bronchiectasis: Comparison with Activity in SerumThe Journal of Infectious Diseases, 1983
- Comparative Studies of Intermittent and Continuous Administration of Aminoglycosides in the Treatment of Bronchopulmonary Infections Due to Gram-Negative BacteriaClinical Infectious Diseases, 1981
- Drug-induced OtotoxicityDrugs, 1980